Asian Markets Rapport Therapeutics Secures Key China Partnership and Advances Clinical Pipeline
Rapport Therapeutics has taken a significant step in its global strategy by forming a partnership with Tenacia Biotechnology to commercialize its lead drug candidate, RAP-219, in China. This move coincides...